Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms
- PMID: 38338799
- PMCID: PMC10855716
- DOI: 10.3390/ijms25031520
Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms
Abstract
Adverse childhood experiences (ACEs), such as abuse, neglect, and household dysfunction, contribute to long-term systemic toxic stress and inflammation that may last well into adulthood. Such early-life stressors have been associated with increased susceptibility to multiple sclerosis (MS) in observational studies and with the development of experimental autoimmune encephalomyelitis in animal models. In this review, we summarize the evidence for an ACE-mediated increase in MS risk, as well as the potential mechanisms for this association. ACEs dysregulate neurodevelopment, stress responses, and immune reactivity; they also alter the interplay between the immune system and neural networks. All of this may be relevant for MS risk. We further discuss how ACEs induce epigenetic changes and how the toxic stress caused by ACEs may reactivate the Epstein-Barr Virus (EBV), a key risk factor for MS. We conclude by suggesting new initiatives to obtain further insights into this topic.
Keywords: MS; abuse; childhood; early; stress; trauma; violence.
Conflict of interest statement
Eid, K. has received unrestricted research grant and speaker honoraria from Novartis. Bjørk, M-H. has received speaker honoraria and/or served on scientific advisory boards for Teva, Eisai, AbbVie, Pfizer, Novartis, Lundbeck, Angelini Pharma, Jazz pharmaceuticals, and Lilly during the last five years, some of which are marked authorization holders of MS drugs. Gilhus, N. has received honoraria from UCB, Argevix, Janssen, Roche, Merck, Alexion, Immunsvant, Huma, Denka, Dianthos, and Grifols for work outside this topic. Torkildsen, Ø. has received speaker honoraria from and/or served on scientific advisory boards for Biogen, Roche, Teva, Sanofi-Aventis, Merck, and Novartis.
Figures

Similar articles
-
The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.Expert Rev Clin Immunol. 2020 Dec;16(12):1143-1157. doi: 10.1080/1744666X.2021.1847642. Epub 2020 Dec 17. Expert Rev Clin Immunol. 2020. PMID: 33152255 Review.
-
Epstein-Barr virus and multiple sclerosis.J Neurol Sci. 2009 Nov 15;286(1-2):62-4. doi: 10.1016/j.jns.2009.03.028. Epub 2009 Apr 10. J Neurol Sci. 2009. PMID: 19361810 Review.
-
Self-reported adverse childhood experiences and quality of life among children in the two last grades of Dutch elementary education.Child Abuse Negl. 2019 Sep;95:104051. doi: 10.1016/j.chiabu.2019.104051. Epub 2019 Jul 23. Child Abuse Negl. 2019. PMID: 31344586
-
Epstein-barr virus infection and multiple sclerosis: a review.J Neuroimmune Pharmacol. 2010 Sep;5(3):271-7. doi: 10.1007/s11481-010-9201-3. Epub 2010 Apr 6. J Neuroimmune Pharmacol. 2010. PMID: 20369303 Review.
-
Case-control study of adverse childhood experiences and multiple sclerosis risk and clinical outcomes.PLoS One. 2022 Jan 13;17(1):e0262093. doi: 10.1371/journal.pone.0262093. eCollection 2022. PLoS One. 2022. PMID: 35025951 Free PMC article.
Cited by
-
Preliminary Evidence for Neuronal Dysfunction Following Adverse Childhood Experiences: An Investigation of Salivary MicroRNA Within a High-Risk Youth Sample.Genes (Basel). 2024 Nov 4;15(11):1433. doi: 10.3390/genes15111433. Genes (Basel). 2024. PMID: 39596633 Free PMC article.
-
Healthcare use is elevated two decades before a first demyelinating event and differs by age and sex.Ann Clin Transl Neurol. 2025 Feb;12(2):415-432. doi: 10.1002/acn3.52267. Epub 2025 Jan 29. Ann Clin Transl Neurol. 2025. PMID: 39887956 Free PMC article.
References
-
- Bjornevik K., Bjornevik K., Cortese M., Cortese M., Healy B.C., Healy B.C., Kuhle J., Kuhle J., Mina M.J., Mina M.J., et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375:296–301. doi: 10.1126/science.abj8222. - DOI - PubMed
-
- Xu Y., Hiyoshi A., Smith K.A., Piehl F., Olsson T., Fall K., Montgomery S. Association of Infectious Mononucleosis in Childhood and Adolescence With Risk for a Subsequent Multiple Sclerosis Diagnosis Among Siblings. JAMA Netw. Open. 2021;4:e2124932. doi: 10.1001/jamanetworkopen.2021.24932. - DOI - PMC - PubMed
-
- Loosen S.H., Doege C., Meuth S.G., Luedde T., Kostev K., Roderburg C. Infectious mononucleosis is associated with an increased incidence of multiple sclerosis: Results from a cohort study of 32,116 outpatients in Germany. Front. Immunol. 2022;13:937583. doi: 10.3389/fimmu.2022.937583. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous